Document is current
Any future updates will be listed below
-
Authors
Glinska, Patrycja https://orcid.org/0000-0003-0165-7568
Komerska, Katarzyna
Janik, Beata
Olkowicz, Julia
Jedrzejewska, Ilona
Macios, Anna
Wieszczy, Paulina
Kaminski, Michal F.
Arbyn, Marc
Nowakowski, Andrzej https://orcid.org/0000-0002-5997-7516
-
Funding
Funding for this research was provided by:
Ministry of Health of Poland (The contract numbered - 1/2-3/1/2020/97/220, “HPV-DNA pilot study”)
- License Information
-
More Information
Article History
Received: 29 April 2022
Accepted: 31 October 2023
First Online: 17 November 2023
Declarations
:
: The study is performed according to the Declaration of Helsinki, Good Clinical Practice, the European Council Convention on Human Rights and Biomedicine and regulations regarding biomedical studies, data protection and bioethics of the Polish law. The project has been accepted by the Ministry of Health in Poland. The screening tests used in the study are in everyday use in the developed countries of the world. Only clinically validated screening tests are used. By the decision of the Ministry of Health informed consent is obtained from each woman recruited into the project. All patients is explained the objectives and process of the study, possible outcomes and risks, and written informed consent is obtained from participants before the first examination. Signed documents on personal data protection and administration are routinely collected in the OCCSP. The study was approved by the Bioethics Committee of National Research Institute of Oncology (ID: 28/2019/1/2020) and prospectively registered on clinicaltrials.gov domain (NCT04111835).
: Not applicable.
: The authors declare that they have no competing interests.
